110518-35-9

Basic information

• Product Name: N2-(1-Oxododecyl)-L-lysine ethyl ester
• Synonyms: Lle;N2-(1-Oxododecyl)-L-lysine ethyl ester
• CAS NO: 110518-35-9
• Molecular Formula: C20H40N2O3
• Molecular Weight: 356.54
• Mol File: 110518-35-9.mol
• Article Data: 6

Chemical Properties

• Boiling Point: 546.8±45.0 °C(Predicted)
• Appearance: /
• Density: 0.981±0.06 g/cm3(Predicted)
• PKA: 3.57±0.10(Predicted)
• CAS DataBase Reference: N2-(1-Oxododecyl)-L-lysine ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: N2-(1-Oxododecyl)-L-lysine ethyl ester(110518-35-9)
• EPA Substance Registry System: N2-(1-Oxododecyl)-L-lysine ethyl ester(110518-35-9)

Safety Data

• Hazardous Substances Data: 110518-35-9(Hazardous Substances Data)

Upstream product

• 16079-52-0 sodium salt of L-lysine 
• 112-64-1 tetradecanoyl chloride 
• 69888-86-4 N-succinimidyl myristate 
• 2418-95-3 (S)-2-amino-6-(tert-butoxycarbonylamino)hexanoic acid 
• 544-63-8 n-tetradecanoic acid 

Relevant articles and documents

COMPOUNDS AND METHODS FOR THE TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

Disclosed herein are compounds including a single-stranded oligonucleotide (A) having a nucleobase sequence complementary to a portion of the dystrophin pre-mRNA, their preparation, and uses thereof for the treatment of Duchenne muscular dystrophy.

LIPID-MODIFIED NUCLEIC ACID COMPOUNDS AND METHODS

Disclosed herein, inter alia, are lipid-modified nucleic acid compounds of the following structure, their preparation, and their use: (I).

Fluorescence polarization method for monitoring fetal lung maturity

The present invention is directed to a fluorescence polarization method for monitoring fetal lung maturity, to various components needed for preparing and carrying out such monitoring, and to methods of making these components.